Teclistamab in Relapsed Refractory Multiple Myeloma: Multi-Institutional Real-World Study

被引：3

作者：

Mohan, Meera ^{[1
]}

Shah, Nishi ^{[2
]}

Luan, Danny ^{[3
]}

Monge, Jorge ^{[4
]}

Forsberg, Mark ^{[5
,6
]}

Bhatlapenumarthi, Vineel ^{[7
]}

Balev, Metodi ^{[8
]}

Patwari, Anannya ^{[9
]}

Cheruvalath, Heloise ^{[10
]}

Bhutani, Divaya ^{[11
]}

Thanendrarajan, Sharmilan ^{[12
]}

Dhakal, Binod ^{[13
]}

Zangari, Maurizio ^{[12
]}

Al Hadidi, Samer ^{[12
]}

Cooper, Dennis L. ^{[14
]}

Lentzsch, Suzanne ^{[15
]}

van Rhee, Frits ^{[12
]}

D'Souza, Anita ^{[16
]}

Szabo, Aniko ^{[9
]}

Schinke, Carolina ^{[17
]}

Chakraborty, Rajshekhar ^{[8
]}

机构：

[1] Med Coll Wisconsin, Dept Med, BMT & Cellular Therapy Program, Milwaukee, WI USA

[2] Montefiore Med Ctr, Oncol, Albert Einstein Coll Med, Bronx, NY USA

[3] Newyork Presbyterian Hosp, Weill Cornell Med Coll, New York, NY USA

[4] Weill Cornell Med, New York, NY USA

[5] Montefiore Med Ctr, Dept Oncol, Bronx, NY USA

[6] Albert Einstein Coll Med, Bronx, NY USA

[7] Med Coll Wisconsin, Dept Hematol Oncol, Milwaukee, WI USA

[8] Columbia Univ, Irving Med Ctr, New York, NY USA

[9] Med Coll Wisconsin, Milwaukee, WI USA

[10] Med Coll Wisconsin, Sch Med, Milwaukee, WI USA

[11] Columbia Univ, Coll Phys & Surg, New York, NY USA

[12] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Myeloma Ctr, Little Rock, AR USA

[13] Med Coll Wisconsin, Wauwatosa, WI USA

[14] Montefiore Med Ctr, New York, NY USA

[15] Columbia Univ, Irving Med Ctr, New York Presbyterian, New York, NY USA

[16] Med Coll Wisconsin Inc, Milwaukee, WI USA

[17] Myeloma Inst, Little Rock, AR USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-174875

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[41] Clinical Outcomes of Teclistamab among MajesTEC-1 Eligible and Ineligible Population in the Real-World Setting for the Treatment of Relapsed/Refractory Multiple Myeloma
Tan, Carlyn
Derkach, Andriy
Maclachlan, Kylee
Hultcrantz, Malin
Hassoun, Hani
Mailankody, Sham
Shah, Urvi
Rajeeve, Sridevi
Hashmi, Hamza
Shah, Gunjan
Scordo, Michael
Chung, David
Landau, Heather
Giralt, Sergio
Lesokhin, Alexander
Korde, Neha
Lin, Dee
Wu, Bingcao
Fowler, Jessica
Fernandez, Mariana
Kim, Nina
Doyle, Margaret
Hester, Laura
Orozco, Jennifer
Usmani, Saad
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S91 - S92
[42] Comparative effectiveness of teclistamab versus real-world treatments for patients with triple-class exposed (TCE), relapsed/refractory multiple myeloma (RRMM).
Krishnan, Amrita Y.
Nooka, Ajay K.
Chari, Ajai
Garfall, Alfred L.
Martin, Thomas G.
Nair, Sandhya
Lin, Xiwu
Qi, Keqin
Londhe, Anil
Pei, Lixia
Eric, Ammann
Kobos, Rachel
Smit, Jennifer
Parekh, Trilok V.
Slavcev, Mary
Usmani, Saad Zafar
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[43] Ambulatory teclistamab administration in patients with relapsed/refractory multiple myeloma
Tabbara, Nadeem
Singel, Michael
Allen, Natalie
Mooney, Kathy
Shedeck, Audra
Zukas, Amber
Campion, Kate
Sollenberger, Callan
Gocke, Christian Burris
Ali, Syed Abbas
Huff, Carol Ann
Imus, Philip H.
Waheed, Sarah
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[44] A real-world observational study of belantamab mafodotin (belamaf) as a treatment for relapsed/refractory multiple myeloma (RRMM)
Cavo, Michele
Delforge, Michel
Dimopoulos, Meletios
Escalante, Fernando
Hultcrantz, Malin
Kleinman, David
Lee, Hans
Vij, Ravi
Kotowsky, Nirali
Camadoo-O'Byrne, Leena
Bitetti, Jacopo
D'Estrube, Tim
Fry, Mark
Vossen, Carla
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S166 - S167
[45] Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study
M. Macro
C. Hulin
L. Vincent
A. Charvet-Rumpler
L. Benboubker
C. Calmettes
A.-M. Stoppa
K. Laribi
L. Clement-Filliatre
H. Zerazhi
F. Honeyman
V. Richez
F. Maloisel
L. Karlin
J. Barrak
C. Chouaid
X. Leleu
Annals of Hematology, 2023, 102 : 2137 - 2151
[46] Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study
Shragai, Tamir
Magen, Hila
Lavi, Noa
Gatt, Moshe
Trestman, Svetlana
Zektser, Miri
Ganzel, Chezi
Jarchowsky, Osnat
Berger, Tamar
Tadmor, Tamar
Leiba, Merav
Hertzog-Tzarfaty, Katrin
Horowitz, Netanel
Shapira, Michael
Varssano, David
Berger, Yoav
Frenkel, Shahar
Krauthammer, Mark
Avivi, Irit
Luttwak, Efrat
Cohen, Yael C.
BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (01) : 45 - 53
[47] Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study
Macro, M.
Hulin, C.
Vincent, L.
Charvet-Rumpler, A.
Benboubker, L.
Calmettes, C.
Stoppa, A. -m.
Laribi, K.
Clement-Filliatre, L.
Zerazhi, H.
Honeyman, F.
Richez, V.
Maloisel, F.
Karlin, L.
Barrak, J.
Chouaid, C.
Leleu, X.
ANNALS OF HEMATOLOGY, 2023, 102 (08) : 2137 - 2151
[48] Real-World Study of Treatment Patterns in Heavily Pretreated Relapsed/Refractory Multiple Myeloma (RRMM) in the US
Wang, Peter Feng
Sansbury, Leah
DerSarkissian, Maral
Ferrante, Shannon
Bhak, Rachel
Gorsh, Boris
Zichlin, Miriam L.
Yee, Christopher W.
Boytsov, Natalie
Khanal, Anamika
Paka, Prani
Noman, Ahmed
Duh, Mei Sheng
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S423 - S423
[49] Belantamab mafodotin (belamaf) for relapsed/refractory multiple myeloma (RRMM): A real-world observational study update
Hultcrantz, Malin
Kleinman, David
Vij, Ravi
Escalante, Fernando
Delforge, Michel
Kotowsky, Nirali
Bitetti, Jacopo
Boytsov, Natalie
Camadoo-O'Byrne, Leena
Powers Happ, Lindsey
Rohman, Mujib
Germain, Guillaume
Duh, Mei Sheng
Laliberte, Francois
Mahendran, Malena
Urosevic, Ana
Lee, Hans C.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[50] Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: a real-world observational study in the United States
Hultcrantz, Malin
Kleinman, David
Vij, Ravi
Escalante, Fernando
Delforge, Michel
Kotowsky, Nirali
Bitetti, Jacopo
Boytsov, Natalie
Camadoo-O'Byrne, Leena
Happ, Lindsey Powers
Germain, Guillaume
Urosevic, Ana
Mahendran, Malena
Duh, Mei Sheng
Laliberte, Francois
Cavo, Michele
Lee, Hans C.
HAEMATOLOGICA, 2025, 110 (03) : 753 - 757

← 1 2 3 4 5 →